Mitchell Levine

Mitchell Levine

Chairman en IMMUNOPRECISE ANTIBODIES LTD. .

Fortuna: 30 400 $ al 31/03/2024

Finance
Health Technology
Consumer Services

Cargos activos de Mitchell Levine

EmpresasCargoInicioFin
IMMUNOPRECISE ANTIBODIES LTD. Chairman 27/11/2023 -
Director/Board Member - 27/11/2023
Chief Executive Officer 01/11/2022 -
Chairman - -

Historial de carrera de Mitchell Levine

Antiguos cargos conocidos de Mitchell Levine.

EmpresasCargoInicioFin
Chief Investment Officer 01/01/2002 01/01/2017
Compliance Officer 01/01/2002 01/01/2017
Founder 27/07/2011 01/01/2017
Cove Capital Advisors, Inc. Corporate Officer/Principal - -
ONCOCYTE CORPORATION Director of Finance/CFO 15/11/2017 01/06/2022
Corporate Officer/Principal 01/06/2022 -
Lehman Brothers Distressed Structured Credit Capital Partners Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -

Formación de Mitchell Levine.

University of California, Davis Undergraduate Degree

Estadísticas

Internacional

Estados Unidos 9
Canadá 2

Operativa

Corporate Officer/Principal 5
Chairman 2
Chief Investment Officer 1

Sectorial

Finance 4
Health Technology 4
Consumer Services 2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas relacionadas

Empresas cotizadas2
ONCOCYTE CORPORATION

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

Empresas privadas6

Finance

Lehman Brothers Distressed Structured Credit Capital Partners

Finance

Finance

Cove Capital Advisors, Inc.

Health Technology

Ver las conexiones de la empresa